All In MedTech

FDA Clearance Tracker · P150011-S028

Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart Valve

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 12, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 12, 2025

Approved

Time to decision

237 days

Received Jul 18, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150011-S028
Device name
Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart Valve
Applicant
Corcym S.r.l.
Applicant location
Saluggia
Received
Jul 18, 2024
Decided
Mar 12, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150011

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

approval for the following manufacturing site: Corcym S.r.l, Via Crescentino sn, 13040 Saluggia (VC) – ITALY, Operations to be performed: manufacturing, packaging, sterilization

Source documents

Other decisions for Corcym S.r.l.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.